Abstract
Optical coherence tomography (OCT) provides real-time, cross-sectional skin images to a depth of up to 2 mm. OCT is a convenient and fast imaging technology that can be used bedside. In dermatology, the pretherapeutic delineation of both actinic keratoses (AK) and keratinocyte carcinomas has been a natural focus for applied OCT research, and more recently OCT research has turned on non-invasive monitoring of treatments. Previous studies have found good agreement between OCT images and histopathological images. Cryotherapy is a fast and easy treatment modality frequently used for the treatment of AK lesions in everyday dermatology practise. Cryosurgery with liquid nitrogen freezes and destroys the epidermis containing the AK. This chapter outlines the capability of OCT to monitor cryotherapy.
Keywords
Optical Coherence Tomography Basal Cell Carcinoma Actinic Keratosis Optical Coherence Tomography Imaging Nonmelanoma Skin Cancer
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
- 1.Mogensen M, Jemec GB. Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg. 2007;33(10):1158–74.PubMedGoogle Scholar
- 2.Mogensen M, Nurnberg BM, Forman JL, Thomsen JB, Thrane L, Jemec GB. In vivo thickness measurement of basal cell carcinoma and actinic keratosis with optical coherence tomography and 20-MHz ultrasound. Br J Dermatol. 2009;160(5):1026–33.PubMedCrossRefGoogle Scholar
- 3.Gambichler T, Orlikov A, Vasa R, Moussa G, Hoffmann K, Stucker M, et al. In vivo optical coherence tomography of basal cell carcinoma. J Dermatol Sci. 2007;45(3):167–73.PubMedCrossRefGoogle Scholar
- 4.Forsea AM, Carstea EM, Ghervase L, Giurcaneanu C, Pavelescu G. Clinical application of optical coherence tomography for the imaging of non-melanocytic cutaneous tumors: a pilot multi-modal study. J Med Life. 2010;3(4):381–9.PubMedPubMedCentralGoogle Scholar
- 5.Khandwala M, Penmetsa BR, Dey S, Schofield JB, Jones CA, Podoleanu A. Imaging of periocular basal cell carcinoma using en face optical coherence tomography: a pilot study. Br J Ophthalmol. 2010;94(10):1332–6.PubMedCrossRefGoogle Scholar
- 6.Mogensen M, Joergensen TM, Nurnberg BM, Morsy HA, Thomsen JB, Thrane L, et al. Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists. Dermatol Surg. 2009;35(6):965–72.PubMedCrossRefGoogle Scholar
- 7.Korde VR, Bonnema GT, Xu W, Krishnamurthy C, Ranger-Moore J, Saboda K, et al. Using optical coherence tomography to evaluate skin sun damage and precancer. Lasers Surg Med. 2007;39(9):687–95.PubMedPubMedCentralCrossRefGoogle Scholar
- 8.Marschall S, Sander B, Mogensen M, Jorgensen TM, Andersen PE. Optical coherence tomography-current technology and applications in clinical and biomedical research. Anal Bioanal Chem. 2011;400(9):2699–720.PubMedCrossRefGoogle Scholar
- 9.Mogensen M, Nurnberg BM, Thrane L, Jorgensen TM, Andersen PE, Jemec GB. How histological features of basal cell carcinomas influence image quality in optical coherence tomography. J Biophotonics. 2011;4(7–8):544–51.PubMedCrossRefGoogle Scholar
- 10.Petrova G, Derpalyek E, Gladkova N, et al. Optical coherence tomography using tissue clearing for skin disease diagnosis. Proc Spie. 2003;5140:168–86.CrossRefGoogle Scholar
- 11.Strasswimmer J, Pierce MC, Park BH, Neel V, de Boer JF. Polarization-sensitive optical coherence tomography of invasive basal cell carcinoma. J Biomed Opt. 2004;9(2):292–8.PubMedCrossRefGoogle Scholar
- 12.Banzhaf CA, Themstrup L, Ring HC, Mogensen M, Jemec GB. Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy. Skin Res Technol. 2014;20(2):170–6.PubMedCrossRefGoogle Scholar
- 13.Themstrup L, Banzhaf CA, Mogensen M, Jemec GB. Optical coherence tomography imaging of Non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions. Photodiagnosis Photodyn Ther. 2014;11(1):7–12.PubMedCrossRefGoogle Scholar
- 14.Hamdoon Z, Jerjes W, Upile T, Hopper C. Optical coherence tomography-guided photodynamic therapy for skin cancer: case study. Photodiagnosis Photodyn Ther. 2011;8(1):49–52.PubMedCrossRefGoogle Scholar
- 15.Cunha D, Richardson T, Sheth N, Orchard G, Coleman A, Mallipeddi R. Comparison of ex vivo optical coherence tomography with conventional frozen-section histology for visualizing basal cell carcinoma during Mohs micrographic surgery. Br J Dermatol. 2011;165(3):576–80.PubMedCrossRefGoogle Scholar
- 16.Pomerantz R, Zell D, McKenzie G, Siegel DM. Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery. Case Rep Dermatol. 2011;3(3):212–8.PubMedPubMedCentralCrossRefGoogle Scholar
- 17.Alawi SA, Kuck M, Wahrlich C, Batz S, McKenzie G, Fluhr JW, et al. Optical coherence tomography for presurgical margin assessment of non-melanoma skin cancer – a practical approach. Exp Dermatol. 2013;22(8):547–51.PubMedCrossRefGoogle Scholar
- 18.Themstrup L, Banzhaf C, Mogensen M, Jemec GB. Cryosurgery treatment of actinic keratoses monitored by optical coherence tomography: a pilot study. Dermatology. 2012;225(3):242–7.PubMedCrossRefGoogle Scholar
- 19.Graham GF, Scott CM. Cryosurgery. In: Riegel D, Friedman R, Dzubow LM, editors. Cancer of the skin. 1st ed. Philadelphia: Saunders; 2004. p. 487–97.Google Scholar
- 20.Sattler E, Kastle R, Welzel J. Optical coherence tomography in dermatology. J Biomed Opt. 2013;18(6):061224.PubMedCrossRefGoogle Scholar
- 21.Gambichler T, Jaedicke V, Terras S. Optical coherence tomography in dermatology: technical and clinical aspects. Arch Dermatol Res. 2011;303(7):457–73.PubMedCrossRefGoogle Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 2015